LIFE: Presentation at MARSS 2024

LIFE: Presentation at MARSS 2024

Issuer

Lifecare AS

Lifecare's Dr. Preeti Sharma is invited as a speaker to present a paper at
International Conference on Manipulation, Automation and Robotics at Small
Scales (MARSS 2024) in Delft, Netherlands.

The paper "Towards Scanning Electron Microscope (SEM) automation" is accepted
by the MARSS 2024 Organization Committee and assigned for an oral presentation
at the conference in July.

MARSS is a non-profit conference run by the microrobotic community and
technically supported by IEEE-RAS and IEEE-NTC. MARSS2024 will be held
in-person on July 1st -5th, 2024, in Delft, Netherlands. The conference is the
flagship forum to discuss cross-disciplinary activities on manipulation,
automation, measurement, and characterization at micro/nano scales, and all
kinds of small-scale robots (nm -- cm) and their applications.

Dr. Preeti Sharma and her co-authors and colleagues in Lifecare, Christoph
Füger, Rustam Gilyazev, Boris Stamm and Prof. Andreas Pfützner have present
the paper about an automated process for precision placement of nanosensors
with real-time quality control.

More recently, SEM combined with a gas injection system has been utilized by
Lifecare for deposition of nanosensors for pressure measurement (Nanogranular
Tunnel- ing Resistors, NTRs). Handling a scanning electron microscope for the
deposition of the NTRs is laborious and time-consuming, especially when it
comes to large-scale production.

Lifecare use a Scanning Electron Microscope (SEM) with customized software to
produce the Sencell - Lifecare's unique sensor for Continuous Glucose
Monitoring applying osmotic pressure as the sensing principle. Sophisticated
3D-printing processes carried out in a SEM enables Lifecare to obtain the
precision necessary to apply pressure sensing elements of a size as small as
40 nanometers (one nanometer corresponding to a millionth of a millimeter).

- Lifecare innovates within nanotechnology, which is a very advanced field.
Our employees are passionate about providing patients with diabetes with
better solutions for monitoring glucose with our Sencell sensor. It is great
to see that our employees' work is appreciated through the invitation to this
important conference, says CEO Joacim Holter at Lifecare.

About us
Lifecare AS is a clinical stage medical sensor company developing technology
for sensing and monitoring of various body analytes. Lifecare's main focus is
to bring the next generation of Continuous Glucose Monitoring ("CGM") systems
to market. Lifecare enables osmotic pressure as sensing principle, combined
with the ability to manipulate Nano-granular Tunnelling Resistive sensors
("NTR") on the sensor body for read-out of pressure variations. Lifecare's
sensor technology is referred to as "Sencell" and is suitable for identifying
and monitoring the occurrence of a wide range of analytes and molecules in the
human body and in pets.

Contacts
For further information, please contact:

Joacim Holter, CEO, Lifecare AS, [email protected], +47 40 05 90 40

Asle Wingsternes, Head of Communications & Public Affairs,
[email protected], +47 41 61 42 52

More information:
Access the news on Oslo Bors NewsWeb site

615852_LIFE- Presentation at MARSS 2024.pdf